Italian leukemia, lymphoma and myeloma associations present the conference "Fighting leukemia … also Lo Sport", the first AIL meeting dedicated to the relationship between sports and blood groups. Onco hematologic patients; to facilitate the removal of cultural and practical barriers to facilitate access to sport and improve their quality of life for adult and childhood cancer events.
Exercise is an effective medicine with an anti-tumor effect. Epidemiological studies have already shown that persistent physical activity is a deterrent to some bloodstream groups; some studies indicate that participation in sport-related programs is the strategy that has the greatest impact on improving the quality of life of hematologic cancer patients in both adults and the elderly. And yet, research conducted in thousands of patients has shown that sport is pursuing life expectancy and reducing the progression and recurrence of the disease.
Despite the scientific evidence, only a small percentage of patients with a blood vessel have been diagnosed after the disease, pursuing the sport with the continuity and intensity required to obtain multiple benefits. There are still important cultural and practical obstacles that do not promote patient access to exercise and must now be considered as a form of medicine – oncologic and on-the-haematological patients. Several clinical and research studies conducted in North America and Northern Europe show that exercise oncology is considered a new subcategory of oncological sciences. The congress will take place on Sunday, November 11, 2018 at Salus Theater, Hall 9, Fiera di Roma, 10.00-13.30.